{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:22:38Z","timestamp":1754601758514},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T00:00:00Z","timestamp":1370908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T00:00:00Z","timestamp":1370908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/mp.2013.74","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T08:00:28Z","timestamp":1370937628000},"page":"403-405","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis"],"prefix":"10.1038","volume":"19","author":[{"given":"A K","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A C","family":"Need","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F W","family":"Lohoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C C","family":"Zai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N I","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Putkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Repo-Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hallikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A E","family":"Anil Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Y","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"BFmp201374_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H . Arch Gen Psychiatry 1988; 45: 789\u2013796.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201374_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11920-011-0185-3","volume":"13","author":"NI Chowdhury","year":"2011","unstructured":"Chowdhury NI, Remington G, Kennedy JL . Curr Psychiatry Rep 2011; 13: 156\u2013165.","journal-title":"Curr Psychiatry Rep"},{"key":"BFmp201374_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2217\/14622416.9.8.1101","volume":"9","author":"C Opgen-Rhein","year":"2008","unstructured":"Opgen-Rhein C, Dettling M . Pharmacogenomics 2008; 9: 1101\u20131111.","journal-title":"Pharmacogenomics"},{"key":"BFmp201374_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","volume":"47","author":"JA Lieberman","year":"1990","unstructured":"Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ . Arch Gen Psychiatry 1990; 47: 945\u2013948.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201374_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4088\/JCP.09m05527yel","volume":"72","author":"MC Athanasiou","year":"2011","unstructured":"Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA et al J Clin Psychiatry 2011; 72: 458\u2013463.","journal-title":"J Clin Psychiatry"},{"key":"BFmp201374_CR6","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.yexcr.2010.06.022","volume":"316","author":"S Mattauch","year":"2010","unstructured":"Mattauch S, Sachs M, Behrens J . Exp Cell Res 2010; 316: 2883\u20132892.","journal-title":"Exp Cell Res"},{"key":"BFmp201374_CR7","doi-asserted-by":"publisher","first-page":"e22764","DOI":"10.1371\/journal.pone.0022764","volume":"6","author":"K Kiok","year":"2011","unstructured":"Kiok K, Sun H, Clancy H, Bose S, Kluz T, Wu F et al PLoS One 2011; 6: e22764.","journal-title":"PLoS One"},{"key":"BFmp201374_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cell.2009.04.042","volume":"138","author":"ME Sowa","year":"2009","unstructured":"Sowa ME, Bennett EJ, Gygi SP, Harper JW . Cell 2009; 138: 389\u2013403.","journal-title":"Cell"},{"key":"BFmp201374_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.cr.7290291","volume":"15","author":"P Mhawech","year":"2005","unstructured":"Mhawech P . Cell Res 2005; 15: 228\u2013236.","journal-title":"Cell Res"},{"key":"BFmp201374_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.autrev.2010.12.009","volume":"10","author":"KG Oikonomou","year":"2011","unstructured":"Oikonomou KG, Zachou K, Dalekos GN . Autoimmun Rev 2011; 10: 389\u2013396.","journal-title":"Autoimmun Rev"},{"key":"BFmp201374_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4049\/jimmunol.1103708","volume":"189","author":"M Gordon-Alonso","year":"2012","unstructured":"Gordon-Alonso M, Sala-Valdes M, Rocha-Perugini V, Perez-Hernandez D, Lopez-Martin S, Ursa A et al J Immunol 2012; 189: 689\u2013700.","journal-title":"J Immunol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp201374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp201374","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp201374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:42:47Z","timestamp":1648780967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BFmp201374"],"URL":"https:\/\/doi.org\/10.1038\/mp.2013.74","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]},"assertion":[{"value":"11 June 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JLK has been a consultant to GSK, Sanofi-Aventis and Dainippon-Sumitomo. HYM has received grants, or payment for lectures, or is or was a consultant to: Abbott Labs, ACADIA, Alkemes, Bristol Myers Squibb, DaiNippon Sumitomo, Eli Lilly, EnVivo, Janssen, Otsuka, Pfizer, Novartis, Roche, Sunovion, TEVA and BiolineRx. HYM is a shareholder of ACADIA, Glaxo Smith Kline and Suregene. HYM is a board member of Acadia, and is an advisor to Centerstone Research Institute. JT is a member of advisory board of AstraZeneca and Janssen-Cilag, and reports serving as a consultant to Lundbeck, Organon, Janssen-Cilag, Eli Lilly, AstraZeneca, F. Hoffman-La Roche, and Bristol-Myers Squibb. He has received fees for giving expert opinions to Bristol-Myers Squibb and GlaxoSmithKline, and lecture fees from Janssen-Cilag, Bristol Myers-Squibb, Eli Lilly, Pfizer, Lundbeck, GlaxoSmithKline, Novartis, and Astra Zeneca. AKT\/ACN\/FWL\/CCZ\/NIC\/DJM\/AP\/ERT\/AEAY declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}